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S  Ul-lfuTlary 
A novel subset ofT ceils characterized by the expression of an invariant T  cell antigen receptor 
(TC1L) encoded by V0t24J~xQ gene segments was investigated in patients with systemic sclerosis 
(SSc).  Polymerase chain reaction analysis  demonstrated that the Vot24 TClL repertoire was se- 
lectively used in CD4-CD8- double-negative T  cells both in patients and in healthy individu- 
als, while almost all families of TCR.Vot were expressed in single-positive T  cell fractions. The 
Vor  + double-negative T cells were increased by approximately fivefold in patients. However, 
sequence analysis  clearly showed significant differences in the Vo~24 TC1L repertoire dominat- 
ing  in  patients  and  healthy  donors.  In healthy  individuals,  the  invariant Vot24JoLQ was  ex- 
panded and comprised 20-50%  of the total TCR-ot,  while their selective reduction  was ob- 
served  in  SSc  patients  who  also  showed  expansion  of invariant  Vex24 TCR  other  than 
Vot24JcxQ.  Analogous to murine invariant V~14JoL281  TC1L, these results suggest that T  cells 
with invariant V&24JotQ TCR would function as regulatory T  cells,  whereas T  cells bearing 
other invariant Vex24 TCR in SSc patients could be autoaggressive T  cells in nature. 
A 
ccumulative evidence demonstrates that there are novel 
T  cell subsets in the thymus characterized by their ex- 
pression of cell-surface phenotypes of NK1.1 and TC1L (1- 
4).  This population belongs to either the  double-negative 
(DN)  CD4-CD8-  or  single-positive  (SP)  CD4+CD8 - 
thymocytes but is apparently distinct from conventional T 
cells  and  NK cells  having the  germ line  configuration  of 
TC1L genes. Recently, NK T  cells have been found to be 
composed of a relatively large fraction of peripheral T  cells 
comprising 5% of splenic T  cells and 40% of bone marrow 
T  cells (4). The most characteristic feature of NK T  cells is 
that the majority bear an invariant TCP, encoded by V0d4 
and Jot281 gene segments with a one-base N  region (4,  5). 
Thus,  invariant Vod4  TC1L is  a  marker for NK T  cells. 
Moreover,  NK T  cells  express a limited  TCR  V[~ reper- 
toire, including V]38, V]37, and V]32 (5). 
Recent studies by Porcelli et al.  (6) and Dellabona et al. 
(7,  8)  indicate  that  the  invariant  Vcx24J~xQ sequence  is 
preferentially expressed on DN ot/]3  T  cells  from healthy 
individuals.  The homology of the  nucleotide  sequences is 
found to be 75% in the V0t24  and 90% in the CDR3  re- 
gions  compared with murine Vo~24 TCR  (9).  Therefore, 
the  human  V&24  sequence  is  a  homologue  of murine 
V&14 TCP,.  Another striking similarity to murine invari- 
ant V~14 T  cells is that human peripheral DN T  cells also 
express a limited TCR.-[3 repertoire including V[32,  V[38, 
VI311,  and V[313  (6-8,  10).  Interestingly,  the  decrease in 
invariant  Vod4Jo~281  TCR  expression  in  autoimmune 
prone mice correlates with disease development. It is thus 
likely that Vot14 § NK T  cells play a role in the regulation 
ofautoimmune disease  development. 
Analogous to murine invariant Vc~14 T  cells, we investi- 
gated invariant Ve~24Jo~Q TCR expression in patients with 
autoimmune diseases,  such as systemic sclerosis  (SSc).  Sur- 
prisingly, invariant Vc~24  + TCR. other than voL24joLQ were 
dominant  in  SSc  patients.  However,  invariant  VoL24Jo~Q 
TCR were undetectable in patients, while 20-50% of TCR. 
expressed in healthy individuals  were invariant voL24JotQ 
TCR..  The  results  indicate  that  T  cells  bearing  invariant 
Vo~24JotQ function as regulatory T  cells, while T  cells with 
other invariant VoL24 TCP, are likely to be autoaggressive 
in patients. 
Materials  and  Methods 
Study Subjects.  Four patients  diagnosed  with  SSc  (11) were 
evaluated  during  the  swelling phase  of SSc. Three  disease-free 
subjects were also examined  as controls. All patients and healthy 
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Chiba University Hospital. 
Flow Cytometry.  PBL  (1  ￿  107) from  20  ml  of peripheral 
blood were isolated by Ficoll-Paque separation (Pharmacia Bio- 
tech Inc., Piscataway, NJ)  and incubated with PE-coupled anti- 
CD4  (Leu-3a) plus anti-CD8 (Leu-2a) mAbs (Becton Dickinson 
& Co., Mountain View, CA) and FITC-conjugated mAb to ot/~ 
TCk  (mAb  WT-31).  The  cells  were  analyzed by  FACScan  ~ 
with a logarithmic amplifier (Becton Dickinson & Co.). 
Purification of DN a/~  T  Cells from  PBL  of SSc  Patients and 
Healthy Subjects.  DN and SP et/I3  T  cells were sorted by FAC- 
Star  |  (Becton Dickinson &  Co.)  using PE-anti-CD4 plus anti- 
CD8 mAbs. The yields of DN and SP T  cells were 10  s and 10  6, 
respectively.  The  purity  of fractionated  DN  samples  was  con- 
firmed by PCF( with CD4 or CD8 primers (see Fig. 1 C). 
Preparation of RNA and PCR.  Total  RNA  (0.1-10  i.Lg) was 
prepared  using Isogen  (Nippon Gene  Co.  Ltd.,  Tokyo, Japan) 
from sorted DN a/J3 T  or SP et/[3  T  cells,  cDNA synthesis and 
PCR were described elsewhere (12).  Briefly, first-strand cDNAs 
were synthesized with oligo(dT) primer using 0.1-1  bLg of total 
RNA. PCR was performed with 21 different Vot and Cot primers 
at 95~  for  1.5 min for denaturation, 62~  for  1.0 min for an- 
nealing, and 72~  for  1.0 rain for extension, for 30 cycles on a 
DNA thermal cycler (Perkin-Elmer Corp.,  Norwalk,  CT).  The 
PCR products were hybridized with a 32p-labeled Cot probe of 
155 bp in length (13).  The sequences of the Vet and Cot primers 
were published previously (6,  14). 
For confirmation of the purity of enriched samples, the cDNA 
from sorted DN ~x/[3 T  cells was  amplified by PCR with CD4 
and  CD8tx  primers  (15),  and  hybridized  with  the  32P-labeled 
EcoKI fragment of the human CD4 gene (16) or the PstI/HincII 
fragment  of the  human  CD8Ot  gene  (17).  The  CD4  or  CD8 
cDNA (1 ng) was used as a positive control. 
Quantitation of Va2 4  + DN T  Cells  from SSc Patients and Healthy 
Subjects.  The  relative amounts of Vet24  +  DN  T  cells in PBL 
were  measured by quantitative PCK.  RNA was  prepared  from 
the sorted DN population derived from 107 of PBL T  cells from 
three  SSc  patients and four healthy subjects,  cDNAs  (10 -6  di- 
luted) were  used for PCR with primers for Vot24  and Ca.  For 
the  standardization curve,  Vot24 +  cDNAs  were  serially diluted 
(corresponding to 0.01-10 pg DNA) and subjected to PCIK with 
Vot24  and Cot  primers.  PCR  products  were  hybridized with  a 
32p-labeled Cot probe, and the intensities of the bands were quan- 
titated by an automated densitometer (Fujix BAS2000; Fujifilm I 
& I Co., Ltd., Tokyo), 
Cloning  and  Sequencing of cDNAs  Encoding  TCR  Vot  Genes. 
Vet24 + cDNAs from DN ot/13 T  cells were amplified by primers 
with  an  Ecot~I  restriction  site  for  Vot24  (5'-CGAATTCCT- 
CAGCGATTCAGCCTCCTAC-3') or Cot  (5'-CGAATTCG- 
GTGAATAGGCAGACAGACTT-3').  DNA  fragments  with 
the  expected  size  after  digestion of PCK products with EcoRI 
were  ligated to  M13mp19  plasmids and sequenced by the  dye 
primer method. 
Plaque Hybridization.  The Vot24 + TCR cDNA libraries were 
generated  by PCR  using RNA  from  the  DN  population with 
primers for the Vot24 and Cot.  Recombinant plaques were trans- 
ferred from DYT plates  to a nitrocellulose membrane (Schleicher 
&  Schuell,  Dassel,  Germany) and were  hybridized either with  a 
Vet24  probe  (5'-CTCAGCGATTCAGCCTCCTAC-3')  or  a 
53-bp JotQ  probe  (5'-CAACCCTGGGGAGGCTATAC-3' for 
5'-JotQ and 5'-AGGCCAGACAGTCAACTGAG-3'  for 3'-JotQ). 
Statistical Analysis.  The  statistical  significance  of the  results 
was determined using the X2-test. 
Results  and Discussion 
Predominant  Expansion of TCR  Ve124  + T  Cells.  FACS  | 
analysis of PBL from three patients with swelling-phase SSc 
clearly showed  that  their DN  or/In T  but not DN  "y/8  T 
cell populations were increased in actual cell number (101/ 
mm  3,  120/ram  3, and 109/mm  3) compared with healthy in- 
dividuals (average 28/ram  3) (Fig. 1 A  and Table 1). The in- 
Figure 1.  FACS  |  profiles and purification of DN et/13 T  cells in PBL 
from SSc patients and healthy subjects. (A) DN et/I3 T cells in PBL from 
three SSc patients (SSc-1, -2, and -3) and a healthy subject (control) were 
analyzed by FACS  |  using PE-anti-CD4 plus anti-CD8 mAb and with 
FITC-WT-31 mAb (6.35, 5.69, 5.17, and 0.8%, respectively). (B) PBLs 
from an SSc patient were stained with PE-anti-CD4 plus anti-CD8 mAb 
and with FITC-WT-31 mAb (left  panel). The DN population (right bottom 
panel) and CD4 and/or CD8 positive T cells (data not shown) were sepa- 
rated by FACStar  |  DN et/13 T  cells were  enriched from 6.4.to 28.6%. 
(C) The purity of the fractionated DN populations was examined by re- 
verse transcription-PCR with CD4 or CD8 primers followed by South- 
ern blot analysis. Lane a, CD4 clone for positive control; lanes b and g, 
SSc-1; lanes c and h, SSc-2; lanes d and i, SSc-3; lanes e and  j, healthy in- 
dividual; lane f, CD8 clone for positive control.  DNA size markers are 
shown to the right (in base pairs). 
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in Peripheral DN  T 
Cell number mm  3. 
Vo~24Jo~Q/ 
Source  total VoL24*  DN ot/[3 T  V~x24Jc~Q  T 
SScDN-1  1/284  w  (0.4%)  101  0.4 
SScDN-2  0/431w  (0.0%)  120  0 
SScDN-3  0/165  w  (0.0%)  109  0 
Control-1  189/379  (49.9%)  25  12.5 
Control-2  31/151  (20.5%)  35  7.0 
Control-3  112/420  (26.7%)  26  6.9 
* Complementary DNA libraries generated by PCR with primers spe- 
cific for VoL24  and Coe were blotted on two separate filters and indepen- 
dently hybridized with  the  VIx24-specific oligonucleotide probe  and 
the JIxQ probe,  respectively. The  ratio of invariant V~24J~Q/total 
VoL24 was calculated by the number of positive plaques. 
~Actual cell number of DN T cells bearing invariant V0~24Jc~Q TCR 
was calculated on the basis of number ofDN oL/13  T cells, since almost 
all DN Ix/[3  T cells were VoL24  +. 
~P <0.001. 
crease ofDN  ci/[3 T  cells in SSc patients was calculated to 
be 3.6- to 4.3-fold compared with those in healthy individ- 
uals.  Thus,  we isolated SP and DN populations from PBL 
by FACS  |  (Fig.  1  B).  The  purity of the  fractionated  DN 
samples was confirmed by reverse transcription-PCR with 
CD4  or CD8 primers  (Fig.  1  C),  and the TCRVo~ reper- 
toire was then analyzed. As shown in Fig. 2, almost all fam- 
ilies  of TCRV~x  expression  were  observed  in  SP  T  cell 
fractions.  Although  individual  VIx  gene  expression  varied 
in each sample,  no significant difference was observed be- 
tween SSc patients and healthy individuals. 
On the  other hand,  very restricted  TCRVcr  expression 
was noted in the DN T  cell population.  The only Vo~ rep- 
ertoire  detected  was  Vc124,  and  in  some  cases  VoL24 and 
Vo~23.  Other  TCRVci  expression  was below  the  level  of 
detection by DNA blot analysis even with longer exposures 
(Fig. 2). The results indicate that the VoL24 TCR  repertoire 
dominates  in  peripheral  DN  T  cells  of both  patients  and 
healthy  individuals.  The  dominant  expression  of Vc124 
TCR  was  further  examined  by  quantitative  PCR.  Vc~24 
expression  in  patients  showed a  four-  to  fivefold increase 
compared with healthy donors (Fig. 3).  Together with the 
FACS  |  data, the results indicate that the number of DN T 
cells,  particularly  Vo~24-bearing  T  cells,  is  higher  in  pa- 
tients,  although the TCR-oL repertoire in the DN popula- 
tion is restricted to Vc~24  in both SSc patients  and healthy 
individuals. 
Oligoclonal Expansion  of Vc~24  TCR  in SSc Patients.  Por- 
celli et  al.  (6)  and Dellabona  et al.  (7,  8)  have shown that 
the Vc~24  TCR  preferentially  used  in DN  oL/[3 T  cells  in 
healthy donors is an invariant TCR  encoded by Vct24 and 
JcxQ gene segments.  Therefore,  we attempted  to compare 
Vc~24 TCR  sequences in DN T  cells between patients and 
Figure 2.  Analysis  of TCRVcx usage in SSc patients and healthy sub- 
jects. PCR products of the DN population (b, d,f  h, j, and/)  and SP T 
cell fraction (a, c, e,g, i, and k) of  three SSc patients (a-3~ and three healthy 
subjects (8--/) were hybridized with the C~x probe. DNA size markers are 
shown to the right (in base pairs); Vix markers are shown across the top. 
healthy  donors.  The  results  are  illustrated  in  Fig.  4.  In 
healthy  individuals,  invariant  Vo~24Jc~Q  TCR  was  domi- 
nant at a high frequency (6/11,  6/7,  and 5/11).  However, 
among  13  in-frame  Vo~24 +  cDNA  clones  in  the  patient 
SSc-1,  four  different Jo~  genes,  IGRJci11, JciG,  JciI,  and 
JclAP511,  were detected  at a frequency of 5/13,  4/13,  3/ 
13, and 1/13,  respectively. Although several distinct Vc~24 
TCR were expressed, we noted clonal expansion ofinvari- 
ant  VoL24  TCR  other  than  Vc~24Jo~Q.  Interestingly,  the 
most dominant invariant Vc~24Jo~Q detected in healthy do- 
nors was not detected  in patients.  Similarly,  in the patient 
SSc-2,  7  of  12  clones  represented  the  Vc124JoLV TCR, 
three  clones  used  the JoLU  gene,  and  two  used  the JccT 
gene. Again, we detected dominant expansion of invariant 
VoL24Jo~V TCR  different  from Vc~24JclQ.  In  the  patient 
SSc-3,  seven different Jcl  genes  (JcxAA17,  J~xT,  IGRJoU1, 
IGRJoU0, Jo~AF211, Jo~U,  and Jo~AP511) were used at fre- 
quencies  of 1/15  to  5/15.  Among them,  invariant  Vo~24 
Jo~AA17  dominated,  while  no  Vc~24JcxQ  sequences  were 
detected  in the patient.  Taken collectively,  the VoL24 rep- 
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Figure 3.  Quantitative PCR analysis of V(x24  + TCR. The number of 
DN  T  cells isolated was  normalized  by counting cell numbers.  Total 
RNA was  extracted  and used  for  PCR  to  measure  the  frequency  of 
Vet24  §  TCR.  PCP,  products  were  hybridized  with  32p-labeled Ca 
probe, and the intensities of autographic bands were quantitated by a den- 
sitometer. The radioactivity of varying concentrations (corresponding to 
0.01-10 pg DNA) of the standard Vet24 cDNA amplified by PCR. was 
compared with that of PCP, products from patients and healthy donors: 
1, SSc-1; 2, SSc-2; 3, SSc-3; and 4, SSc-4 for SSc patients, and CI, C2, 
and C3 for healthy donors. The relative radioactivities of samples from 
four SSc patients are 67.9, 79.5, 89.5, and 93.1, respectively, all of which 
are significantly higher than the mean value of the control group (19.2 • 
1.2; P <0.0005). 
ertoire  of DN  c~/13 T  cells in PBL was basically heteroge- 
neous, but with apparent oligoclonal expansion ofinvariant 
Vo~24 TCR  in both patients and healthy individuals. How- 
ever,  in healthy donors,  invariant Vet24Jc~Q  TCR  always 
dominated,  whereas,  in  SSc  patients,  invariant Vot24Je~Q 
TCI:k  disappeared  and  oligoclonal  expansion  of other  in- 
variant Ve~24 TCR  was observed. 
Selective Loss of T  Cells Bearing Invariant  Vc~24JotQ TCR. 
As  shown  in  Fig.  4,  the  invariant  Ve~24Jo~Q  TCR  was 
found in healthy subjects at  a  high  frequency  (45-86%  of 
total  Ve~24  TCR),  while  it  was  not  detected  in  SSc  pa- 
tients. To confirm the above findings, cDNA libraries gen- 
erated by PCR  were hybridized with the Vet24 probe and 
the Jo~Q  probe.  Frequencies of invariant vet24Je~Q  TCR 
among total Vo~24  TCR  sequences were  estimated by the 
number of positive plaques and expressed as the ratio of in- 
variant Vot24Je~Q to total Vot24.  As shown in Table 1, the 
invariant Ve~24Je~Q  TCR  was  hardly  detected  in  all  SSc 
patients  (0.4%,  0%,  0%),  while  it was  expressed  at  a  high 
frequency of 21-50% in healthy donors. Based on the cal- 
culation  of actual  cell  number  of DN  e~/~  T  cells,  the 
number of T  cells bearing invariant Vo~24J(xQ  was  in the 
Materials  V~  N  Ja  Frequen=y 
94  104 
8ScDN-I 
GTGGTGAGC  GCGGAGGGCC  ATGGGAACAACAGACTCGCT-IGRJG21  5/13 
GTG  CGCAC  GAAGGGCTCTAGCAAAACAA  GCAAACTAATC  -  JaG  4 /  13 
GTGGTGAGC  CCTCGA  AACACCGACAAGCTCATC  -JUX  3  /  13 
GTGGTG  AGCGGTG  CAGGAACCTACAAATAGATC  -  JaAP  521  1/13 
88cDN-2 
GTGGTG  CCCGGACTCGAT  TCTGGGGCTGGGAGTTACCAACTTACT-J(I'%" 
GTGGTG 
GTGGTGAGC 
8B~DN-3 
GTGGTG 
GTGGTGAGC 
GTGGTGAGC 
GTG 
GTGGTG 
GTGGTGAGC 
GTGGTG 
GTATCACA 
GGA 
7112 
CGGTAACCAGTTCTAT-JGIJ  3  /  12 
GGAAGCTACATACCTACA  -JUT  2 /  12 
ACCCGAAATA  CCGGCACTGCCAGTAAACTCACC  -  JOJtA17  5/15 
CCTCCA  TCATC  AGGAGGAAGCTACATAC  CTAC  A  -  JGT  2/15 
TTCT  ATGGGAACAACAGACTCGCT  -  ZGR~Tal  I  2/15 
CGTCT  CAATGACATGCGC  -  IG~a10  2/15 
AGTCCGGAGA  ACTATGGTCAGAATTTTGTC  - J~AF2 :L  1  2  /  1  5 
GCGCTCCT  CGGTAACCAGTTCTAT  -  J~XU  1  /  15 
TATA  CCTCAGGAACCTACAAATACATC  -  JGAP  511  1/15 
Control-I 
GTGGTGAGC 
GTGGTGAGC 
GTGGTGAGC 
GTGGTGAGC 
GTG 
GTG 
Control-2 
GTGGTGAGC 
GTG 
Control-$ 
GTGGTGAGC 
GTGGTGAGC 
GTGGTGAGC 
GTGGTGAGC 
GTGGTG 
GTGGTGAGC 
GTGGTG 
GACAGAGGCTCAACCCTGGGG  -  JUQ  6  /  11 
TCCACCTCT  TC  AGGAAC  CTACAAATACATC  -  JGAPS  I  1  1  /  11 
GAGAC  GGCA GAACTGCTCTGATC  -  JGS  1  /  11 
CCGTCGG  ACAATGCCAGAC  TCATG  -  JGR  1  /  ~L  1 
TGGTGTCCGG  ATTCAGGATACAGCAC  C  CTCACC  -  JOJ&DI?  1  /  11 
AGTGA  ATCAGGAGGAAGCTACATACC  TACA  -  J(E~J&P  $  IG  I/II 
AGGGAT 
GACAGAGGCTCAACCCTGGGG  -  JGQ  6  /  7 
TCAGGAAACACACCTCTTGTC  -JaF  1  /  7 
GACAGAGGCTCAACCCTGGGG  -  JuQ  5  /  11 
GCGCTGT  TGGATAGCAGCTAT  -  JGB  1  /  11 
GCGGGGTTCGGGAG  AGC~ - IQR~rG02G  I/Ii 
GAAAG  GGGAGGAGGAAACAAACTCACC  -  JGJA210G  I/Ii 
ACCGATA  CCGGCACTGCCAGTAAACTCACC  -  JGAKI  ?  1  /  Ii 
GCG  AACAATGACATGCGC-  ZGItJGI0  1  /  11 
GCCC  CATCAGGAGGAAGCTACATACCTACA  -  JO-qRJP5  IQ  I/Ii 
Figure 4.  Junctional sequences of Vow24 TCB. ob- 
tained from  DN ~x/[~ T  cells in SSc patients. The 
Vet24  + cDNA clones were  randomly  isolated from 
the PCR-amplified libraries from  the DN  popula- 
tion.  Multiple  isolates from  each cDNA  were  se- 
quenced.  Nucleotide  sequences of the 3'  of TCP, 
Vet,  N  region,  and  the  5'  of the Jet  region  are 
aligned. The frequency of identical sequences defined 
is shown in the tight margin. These TCP,. Vet andJa 
sequences have been previously published (6, 20-23). 
1166  Invariant Ve~24 TCR in Patients with Systemic Sclerosis range of 0--0.4/mm  3 in SSc patients and 6.9-12.5/mm 3 in 
the healthy donors (see Table 1). This indicates that the de- 
crease in the expression of invariant Vet24JetQ TCR  is due 
to the selective loss of T  cells bearing invariant Vot24~otQ, 
and not to the relative increase in the number of Vet24 + T 
cells in SSc patients. 
The  predominant  expression  of invariant  Vcd4Jot281 
TCR  on  the  DN  T  cell  population  in  the  periphery  has 
been reported in mice (18, 19). The most characteristic fea- 
ture  of invariant  Vet14 TCR  with  regard to autoimmune 
diseases  is  that  there  is  a  striking  inverse  correlation  be- 
tween  autoimmune  disease  development  and  the  expres- 
sion of invariant Vet14  TCK.  In fact,  invariant Vot14 ex- 
pression  declines  selectively  with  time  after  birth  and 
disappears  when  mice  develop  autoimmune  diseases  in 
(NZB  X  NZW)F1,  lpr, or gld  mice  (9).  Moreover,  the 
treatment  of young lpr mice with  anti-Vex14  antibody in 
vivo  induces  splenomegaly  at  least  threefold  greater  than 
that  in  untreated  lpr mice  at  the  same  age,  indicating  the 
augmentation and acceleration  of lymphoproliferative  dis- 
orders.  These  results  suggest  that  invariant  Veal4  T  cells 
function as regulatory T  cells that control autoimmune dis- 
ease  development.  Based on the above analogy to murine 
invariant  Vot14  TCR,  it  is  likely  that  human  invariant 
vot24jtxQ  TCR  should play a  decisive  role  in  regulating 
the development ofautoimmune disease. 
Contrary to the  invariant Vct24JetQ TCR,  DN  et/[3  T 
cells  in  SSc patients  showed  oligoclonal  expansion  of in- 
variant Vot24 TCR  other than Vet24JotQ, including Vex24 
IGRJot11,  Vc~24JotG,  VoL24JegV, and  Vot24JetAA17  (Fig. 
4). Our previous studies have shown that the TCRV[3 rep- 
ertoire in DN T  cells is limited to one or two V[3 genes in 
an individual patient, such as V[35, V[37, or V[311 (15). Be- 
cause invariant Vtx24JotQ TCIL has been shown to be asso- 
ciated  with  skewed  V[3,  such  as  V132, V[38,  V1311,  and 
V[313 (6-8,  10), the restricted V[3 usage that predominated 
in patients was different from that seen in healthy donors. 
In  addition,  these  invariant  Ve~24  TCR  sequences  were 
not  detected  in  healthy  individuals.  Thus,  they  might be 
unique to SSc patients,  suggesting that the expanded oligo- 
clonal invariant Vot24 TCIL in SSc patients could be auto- 
aggressive T  cells  in  autoimmune  status.  Sequence  differ- 
ences in the  oligoclonal Vot24 TCK  that dominate in SSc 
patients  might reflect  differences  in  the  polymorphism  of 
restriction  elements  or in  epitope  specificities.  The  estab- 
lishment ofT cells bearing invariant Vot24 TCR  other than 
Ve~24JetQ  from  SSc  patients  will  provide  a  clue  to  the 
mechanisms of autoimmune diseases. 
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